Regorafenib in Combination With Pembrolizumab or Pembrolizumab for MSI-H Colorectal Cancer

Clinical trial NCT06006923 · TERMINATED

Trial details

NCT number: NCT06006923
Sponsor: Anwaar Saeed
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

MSI-H Colorectal Cancer

Start date: 2024-06-26
Primary completion: 2025-07-11
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.